Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Crotalidae Polyvalent Immune Fab (ovine), marketed under the brand name CroFab, is a sterile, non-pyrogenic, purified, polyvalent preparation of ovine-derived Fab (fragment antigen-binding) fragments. It is produced by immunizing sheep with the venom of four North American crotalid snakes: *Crotalus atrox* (Western Diamondback rattlesnake), *Crotalus adamanteus* (Eastern Diamondback rattlesnake), *Crotalus scutulatus* (Mojave rattlesnake), and *Agkistrodon piscivorus* (Cottonmouth or Water Moccasin). The Fab fragments work by binding to and neutralizing venom toxins, facilitating their redistribution away from target tissues and subsequent elimination from the body. It is indicated for the management of adult and pediatric patients with North American crotalid envenomation, including bites from rattlesnakes, copperheads, and cottonmouths.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on crotalidae polyvalent immune fab (ovine).